These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16409202

  • 1. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
    Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L.
    Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during allergen challenge.
    Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Donati MB, Iacoviello L.
    Int Arch Allergy Immunol; 2007 Feb; 144(3):240-6. PubMed ID: 17579282
    [Abstract] [Full Text] [Related]

  • 3. Analysis of -675 4 g/5 G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients.
    Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S, Donati MB, Iacoviello L.
    J Investig Allergol Clin Immunol; 2008 Feb; 18(4):284-92. PubMed ID: 18714537
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY, Ataç FB, Ogus E, Ozbek N.
    Allergy Asthma Proc; 2009 Feb; 30(1):41-6. PubMed ID: 19063817
    [Abstract] [Full Text] [Related]

  • 5. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population.
    Bucková D, Izakovicová Hollá L, Vácha J.
    Allergy; 2002 May; 57(5):446-8. PubMed ID: 11972486
    [Abstract] [Full Text] [Related]

  • 6. Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge.
    Kowal K, Moniuszko M, Zukowski S, Bodzenta-Lukaszyk A.
    Folia Histochem Cytobiol; 2010 Dec; 48(4):518-23. PubMed ID: 21478092
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
    Ma Z, Paek D, Oh CK.
    Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A, D'Agostino R, Rich SS, Jenny NS, Tracy RP, Haffner SM.
    Circulation; 2003 May 20; 107(19):2422-7. PubMed ID: 12719278
    [Abstract] [Full Text] [Related]

  • 13. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 20; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 14. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
    Ringelstein M, Jung A, Berger K, Stoll M, Madlener K, Klötzsch C, Schlachetzki F, Stolz E.
    J Neurol; 2012 Nov 20; 259(11):2287-92. PubMed ID: 22527222
    [Abstract] [Full Text] [Related]

  • 15. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr 20; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 16. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb 20; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 17. Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.
    Zietz B, Buechler C, Drobnik W, Herfarth H, Schölmerich J, Schäffler A.
    Endocr Res; 2004 Aug 20; 30(3):443-53. PubMed ID: 15554360
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.